Chapter Five - Big Pharma’s Blank Check

CHAPTER FIVE

Big Pharma’s Blank Check

IF LOBBYING IS a casino, Big Pharma is the house.

No one spends more. No one plays dirtier.
And no one gets a better return on their investment.

Pharmaceutical companies have turned the U.S. government into a profit-maximizing partner. Shaping drug prices, patent laws, marketing rules, and approval pipelines to protect their bottom line, not your health.

They don’t just sell you medicine.
They sell you policy.
And they bill your body for it.

Let’s start with the obvious:
American drug prices are the highest in the world.

Not because our drugs are better.
Not because they cost more to make.
Not because of “free market magic.”

But because Congress lets them.

In most developed countries, the government negotiates directly with pharmaceutical companies to keep drug prices low. They use centralized bargaining power to protect citizens from price gouging.

The U.S.?
Not allowed.

Thanks to a law written with help from pharmaceutical lobbyists, Medicare, the country’s largest drug buyer, was prohibited from negotiating drug prices for nearly two decades.

That's not capitalism. That's policy capture.

Insulin was discovered in 1921.
Its inventors sold the patent for $1, believing it belonged to the world.

Today?
In America, a month’s supply can cost $300 to $600, even though it costs about $6 to manufacture.

Why?
Because insulin manufacturers lobbied for extended patents, regulatory protections, and loopholes that let them dominate the market and keep cheaper generics off the shelves.

Three companies, Eli Lilly, Novo Nordisk, and Sanofi, control almost the entire U.S. insulin market.
And they’ve spent hundreds of millions to keep it that way.

Big Pharma doesn’t just influence prices.
It influences truth.

Lobbyists work with pharmaceutical companies to ghostwrite medical journal articles promoting their drugs, fund research that’s conveniently favorable to their products, sponsor doctors and hospitals who prescribe them, and even pressure the FDA during the approval process.

This isn’t rare. It’s routine.

One infamous case?
The opioid crisis.

Companies like Purdue Pharma funded “research,” paid doctors, and lobbied lawmakers to downplay the risk of addiction from drugs like OxyContin.

Then the overdoses started.
Then the lawsuits.
Then the settlements.

But by then, they’d made billions, and the damage was done.

You’d think the Food and Drug Administration would protect us.
And sometimes it tries. But let’s be real: they’re outgunned.

Pharma lobbyists routinely push for faster approval timelines, looser testing standards, expanded off-label use, and “User fees” that make the FDA dependent on the very companies it’s supposed to regulate.

That’s right, drug companies pay fees to the FDA to speed up drug reviews.
It’s like a fast pass to the front of the regulatory line.

What could go wrong?

Lawmakers get campaign donations.
Ex-regulators get consulting gigs.
Doctors get speaking fees.
Universities get grants.
Media outlets get ad revenue.

And patients?
They get the bill.

Big Pharma isn’t just an industry.
It’s a lobbying empire, one that treats your life like a subscription model.

And if you can’t pay?
That’s not their problem.
That’s “the market.”

They tell you healthcare is expensive because it’s complicated.
Because it’s advanced.
Because of “innovation.”

But here’s the truth:

Healthcare in America is expensive because it’s profitable.
Because it was designed to be.
Because they wrote the rules.
And they paid top dollar for the pen.